Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 3 | 1 | 5 | 5 | 5 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| +8.7% |
|
| -6.1% |
|
| +100.3% |
|
| +60.0% |
|
| +63.9% |
|
| +37.2% |
CompanyOverview
- Company Name：Innovacell Inc
- Business：便失禁、尿失禁疾患などを対象とした再生医療等製品の開発、製造及び販売.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on TSE-Growth.
- The company size is that assumed market capitalization is
approx. 450 Million JPY (excluded public offering), approx. 563 Million JPY (included public offering).
- The lead manager is 野村.
https://www.innovacell.co.jp/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 450 Million JPY (excluded new issues), approx. 563 Million JPY (included new issues).
- The total amount of new issues is 113.4 Million JPY.
- The total amount of public offering is 28.3 Million JPY.
- The dilution ratio from the new issues is 25%.
- Rate of offering is aprrox. 6%.
- The number of outstanding shares is 33,335,702 shares (excluded new issues),
41,735,702 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 4,843,502 shares.
- Date of 180-day lockup release (initially scheduled) is August 22, 2026.
■ Book building schedule | Payment schedule
- Book building Period *1：February 5, 2026(Thu.) - February 10, 2026(Tue.)
- Priced date *2 ：February 12, 2026(Thu.)
- Payment Period *3 ：February 13, 2026(Fri.) - February 18, 2026(wed.)
- Listing Date ：February 24, 2026(Tue.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 135,000 JPY.)
pending- Tentatively price range：1290 JPY - 1350 JPY
- Public offering price：1350 JPY
- The initial price on listed：1248 JPY(-7.6％)
- Newly Issued Shares：8,400,000 shares (Domestic：4,600,300 shares ＋ Overseas：3,799,700 shares)
- Public offering shares：2,094,000 shares (Domestic：1,775,400 shares ＋ Overseas：318,600 shares)
- Number of domestic unit：63,757 Unit
- The lead manager is 野村證券.
- The another securities companies are ＳＢＩ証券.
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Application period | 2026-02-04 | | 1290 - 1350 JPY | |
| Priced | 2026-02-12 | | | 1350 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Application period | 2026-02-04 | 8,400,000 | 0 | 2,094,000 | 725,300 | 0 | 1,368,700 | 0 |
| Priced | 2026-02-12 | 8,400,000 | 3,799,700 | 2,094,000 | 406,700 | 318,600 | 1,368,700 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
